Skip to content

Effectiveness of two intensive counselling methods for smoking cessation and relapse prevention in persons with coronary heart disease

Effectiveness of two intensive counselling methods for smoking cessation and relapse prevention in persons with coronary heart disease - Smoking Cessation among Patients with Coronary Heart Disease - SCPCH

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32953
Enrollment
798
Registered
2009-09-02
Start date
2009-11-02
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'heart disease' and 'coronary heart disease'

Interventions

The interventions consist of intensive counselling by smoking cessation professionals, either by telephone in one intervention and by face-to-face counselling in the other. These comparable interven

Sponsors

Open Universiteit Nederland
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who are admitted with coronary heart disease at cardiac wards and smoked at least five cigarettes a week prior to hospital admission will be recruted. Inclusion criteria are: - stable cardiac situation - one of the following diagnoses: angina pectoris, myocardial infarction, post-PCI, post-CABG or a combination - 18 years or older - sufficiently fluent in Dutch and able to read Dutch.

Exclusion criteria

Exclusion criteria: Exlusion criteria are: - unstable cardiac situation - terminal stage of the disease - smoking less than 5 cigarettes per week - smoking cessation more than one month prior to hospital admission - insufficiently fluent in Dutch.

Design outcomes

Primary

MeasureTime frame
Primary outcome will be point prevalence abstinence from smoking (PPA) after 6 and 12 months. PPA is considered to be the most sensitive and valid measure of smoking cessation.

Secondary

MeasureTime frame
Secondary outcomes will be continued abstinence, quit attempts, lapses and relapse into smoking. Health outcomes that will be measured are new coronary events, hospital readmissions for coronary events, TC/HDL cholesterol ratio, blood pressure, prescribed medication, number of visits to the cardiologist since discharge. In telephone interview after 6 and 12 months will assess: visits to general practitioner in past months, cardiology outpatient visits in past months, hospitalisations in past months and death related to cardiovascular disease, contacts with caregivers, absence from work due to illness, and resource use specifically for the interventions. Patients who die during the study will directly be excluded from the study to avoid any further contact with family. OTHER MEASUREMENTS The baseline measurement (questionnaire) and the 6 and 12 months post-test (telephone interview) will also include factors that are related to smoking cessation and/ or relapse among this patient population. These include: - demographics; - smoking related factors (smoking history, addiction); - disease related factors (severity of disease, diagnosis); - BMI; - psychological state (depression, anxiety, type D behaviour); smoking cessation related cognitions (for example attitude, selfefficacy, smoking behaviour of important others) only measured baseline

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)